# <scp>AURIEL</scp> ‐PsO: a randomized, double‐blind phase <scp>III</scp> equivalence trial to demonstrate the clinical similarity of the proposed biosimilar <scp>MSB</scp> 11022 to reference adalimumab in patients with moderate‐to‐severe chronic plaque‐type psoriasis

> Research article (British Journal of Dermatology, 2019) · cited 64× · AI/ML

**Wikidata**: [openalex:W2952089805](https://www.wikidata.org/wiki/openalex:W2952089805)  
**Source**: https://4ort.xyz/entity/scp-auriel-scp-pso-a-randomized-doubleblind-phase-scp-iii-scp-equivalence-trial-to-demonstrate-the-clinical-similarity-o